Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
9
×
detroit blog main
detroit top stories
fda
9
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
9
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
9
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
deals
investing
cancer
clinical trials
nonalcoholic steatohepatitis
pfizer
astrazeneca
regeneron pharmaceuticals
alzheimer's disease
amag pharmaceuticals
What
roundup
bio
biotech
cancer
develop
drug
amid
annual
attention
bombast
caught
coronavirus
days
debate
discussion
disease
efforts
growing
meso’s
miss
nash
news
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
according
acquisitions
ahead
akcea
alliance
alzheimer’s
ambien
american
announced
approved
Language
unset
Current search:
fda
×
biotech
×
" raleigh-durham top stories "
×
" cancer immunotherapy "
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More